Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcadia Biosciences, Inc. Director's Dealing 2015

Oct 5, 2015

35424_dirs_2015-10-05_080e47df-5480-403f-8621-dbf1d59d943f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-10-02

Reporting Person: Brandwein Steven F. (VP Finance and Administration)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-02 Common Stock M 10000 $1.08 Acquired 22500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-02 Employee Stock Option (right to buy) $1.08 M 10000 Disposed 2018-06-30 Common Stock (10000) Direct

Footnotes

F1: The option is fully exercisable as of the date hereof.